30.40
Schlusskurs vom Vortag:
$30.64
Offen:
$30.52
24-Stunden-Volumen:
228.70K
Relative Volume:
0.58
Marktkapitalisierung:
$1.30B
Einnahmen:
$384.90M
Nettoeinkommen (Verlust:
$-851.00K
KGV:
-1,520.00
EPS:
-0.02
Netto-Cashflow:
$12.83M
1W Leistung:
-2.53%
1M Leistung:
+0.50%
6M Leistung:
-1.23%
1J Leistung:
+10.67%
Artivion Inc Stock (AORT) Company Profile
Firmenname
Artivion Inc
Sektor
Branche
Telefon
(770) 419-3355
Adresse
1655 ROBERTS BOULEVARD N W, KENNESAW
Vergleichen Sie AORT mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
AORT
Artivion Inc
|
30.40 | 1.47B | 384.90M | -851.00K | 12.83M | -0.02 |
![]()
ABT
Abbott Laboratories
|
125.73 | 228.77B | 43.11B | 13.98B | 6.66B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
103.16 | 153.09B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
395.15 | 149.27B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
91.65 | 114.31B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
76.30 | 45.06B | 5.54B | 4.18B | 623.10M | 7.00 |
Artivion Inc Stock (AORT) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-06-17 | Eingeleitet | Canaccord Genuity | Buy |
2024-10-23 | Eingeleitet | JMP Securities | Mkt Outperform |
2022-09-27 | Bestätigt | Lake Street | Buy |
2022-08-08 | Eingeleitet | Lake Street | Buy |
2022-03-03 | Eingeleitet | Stifel | Buy |
Artivion Inc Aktie (AORT) Neueste Nachrichten
3 Healthcare Stocks with Warning Signs - FinancialContent
What analysts say about Artivion Inc. stockDynamic profit expansion - Autocar Professional
Artivion Inc. Stock Analysis and ForecastHigh-yield portfolio picks - jammulinksnews.com
Is Artivion Inc. a good long term investmentExceptional market positioning - jammulinksnews.com
What drives Artivion Inc. stock priceExceptional return forecasts - Autocar Professional
Artivion Data Breach Lawsuit Investigation - Claim Depot
Artivion Inc. Data Breach Exposes Health Info & Social Security Numbers - Claim Depot
Principal Financial Group Inc. Has $5.08 Million Stock Holdings in Artivion, Inc. (NYSE:AORT) - Defense World
Prosthetic Heart Valve Market May See a Big Move | Major Giants- Artivion, Medtronic, LivaNova - newstrail.com
How Artivion Inc. stock performs during market volatilityFree Access to Community - Newser
Why Artivion Inc. stock attracts strong analyst attentionFree Smart Money Stock Analysis - Newser
What makes Artivion Inc. stock price move sharplyFree Stock Market Knowledge Sharing - Newser
DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating - GlobeNewswire
Tandem Diabetes, Solventum, LeMaitre, UFP Technologies, and Artivion Stocks Trade Down, What You Need To Know - TradingView
Artivion Inc stock reaches 52-week high at 32.38 USD By Investing.com - Investing.com South Africa
AtriCure Data Breach Lawsuit Investigation - Claim Depot
Artivion Inc. Data Breach Affects 5,608 in Texas: SSNs Exposed - Claim Depot
Is Artivion (NYSE:AORT) Using Too Much Debt? - simplywall.st
New York State Teachers Retirement System Cuts Stock Position in Artivion, Inc. (NYSE:AORT) - Defense World
GAMMA Investing LLC Has $53,000 Stake in Artivion, Inc. (NYSE:AORT) - Defense World
Illinois Municipal Retirement Fund Boosts Stake in Artivion, Inc. (NYSE:AORT) - Defense World
Artivion, Inc.(NYSE: AORT) added to Russell 2000 Defensive Index - MarketScreener
State of Alaska Department of Revenue Sells 483 Shares of Artivion, Inc. (NYSE:AORT) - Defense World
Artivion (AORT) Shares Soar 2.02% on Buy Signal, Reach 2025 High - AInvest
Insiders At Artivion Sold US$4.5m In Stock, Alluding To Potential Weakness - 富途牛牛
Artivion SVP Stanton sells $442k in company stock By Investing.com - Investing.com Canada
Artivion SVP Stanton sells $442k in company stock - Investing.com
Artivion Insider Sold Shares Worth $442,500, According to a Recent SEC Filing - MarketScreener
Artivion (NYSE:AORT) Now Covered by Canaccord Genuity Group - Defense World
Artivion (AORT) Receives 'Buy' Rating from Canaccord Genuity | A - GuruFocus
Artivion (AORT) Receives 'Buy' Rating from Canaccord Genuity | AORT Stock News - GuruFocus
Canaccord Genuity initiates Artivion stock with buy rating on aortic repair bets - Investing.com India
Artivion (AORT) Initiated with Buy Rating by Canaccord Analyst | AORT Stock News - GuruFocus
Rhumbline Advisers Cuts Holdings in Artivion, Inc. (NYSE:AORT) - Defense World
Artivion, Inc. (NYSE:AORT) Sees Large Increase in Short Interest - Defense World
Kalkine: What Puts Artivion (NYSE:AORT) in Focus Across NYSE Composite Healthcare Movers? - Kalkine Media
Artivion to Participate in Upcoming Investor Conferences | AORT Stock News - GuruFocus
Artivion to Participate in Upcoming Investor Conferences - Eastern Progress
Artivion Inc (AORT) Trading Down 3.65% on Jun 2 - GuruFocus
Finanzdaten der Artivion Inc-Aktie (AORT)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):